vs
Side-by-side financial comparison of Honest Company, Inc. (HNST) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
Honest Company, Inc. is the larger business by last-quarter revenue ($78.1M vs $61.6M, roughly 1.3× ORTHOPEDIATRICS CORP). On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs -19.7%). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs -8.4%).
The Honest Company, Inc. is an American digital-first consumer goods company, based in Los Angeles and founded by actress Jessica Alba, Christopher Gavigan, and Brian Lee. The company had $319 million in 2021 sales, and was valued at roughly $550 million as of February 2022. Carla Vernón, Chief Executive Officer, is one of the first Afro-Latina CEOs of a U.S. publicly traded company. The Honest Company has raised multiple rounds of venture capital, and went public via an initial public offeri...
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
HNST vs KIDS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $78.1M | $61.6M |
| Net Profit | — | $-10.1M |
| Gross Margin | 42.6% | 73.2% |
| Operating Margin | 56.6% | -13.3% |
| Net Margin | — | -16.4% |
| Revenue YoY | -19.7% | 17.0% |
| Net Profit YoY | — | 37.1% |
| EPS (diluted) | $0.00 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $78.1M | — | ||
| Q4 25 | $88.0M | $61.6M | ||
| Q3 25 | $92.6M | $61.3M | ||
| Q2 25 | $93.5M | $61.1M | ||
| Q1 25 | $97.3M | $52.4M | ||
| Q4 24 | $99.8M | $52.7M | ||
| Q3 24 | $99.2M | $54.6M | ||
| Q2 24 | $93.0M | $52.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-23.6M | $-10.1M | ||
| Q3 25 | $758.0K | $-11.8M | ||
| Q2 25 | $3.9M | $-7.1M | ||
| Q1 25 | $3.3M | $-10.7M | ||
| Q4 24 | $-809.0K | $-16.1M | ||
| Q3 24 | $165.0K | $-7.9M | ||
| Q2 24 | $-4.1M | $-6.0M |
| Q1 26 | 42.6% | — | ||
| Q4 25 | 15.7% | 73.2% | ||
| Q3 25 | 37.3% | 73.9% | ||
| Q2 25 | 40.4% | 72.1% | ||
| Q1 25 | 38.7% | 73.0% | ||
| Q4 24 | 38.8% | 67.5% | ||
| Q3 24 | 38.7% | 73.4% | ||
| Q2 24 | 38.3% | 77.3% |
| Q1 26 | 56.6% | — | ||
| Q4 25 | -27.5% | -13.3% | ||
| Q3 25 | 0.3% | -15.4% | ||
| Q2 25 | 3.1% | -17.4% | ||
| Q1 25 | 2.6% | -21.0% | ||
| Q4 24 | -1.0% | -26.7% | ||
| Q3 24 | 0.1% | -10.2% | ||
| Q2 24 | -4.3% | -10.7% |
| Q1 26 | — | — | ||
| Q4 25 | -26.8% | -16.4% | ||
| Q3 25 | 0.8% | -19.2% | ||
| Q2 25 | 4.1% | -11.6% | ||
| Q1 25 | 3.3% | -20.3% | ||
| Q4 24 | -0.8% | -30.5% | ||
| Q3 24 | 0.2% | -14.5% | ||
| Q2 24 | -4.4% | -11.4% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | $-0.21 | $-0.43 | ||
| Q3 25 | $0.01 | $-0.50 | ||
| Q2 25 | $0.03 | $-0.30 | ||
| Q1 25 | $0.03 | $-0.46 | ||
| Q4 24 | $-0.01 | $-0.70 | ||
| Q3 24 | $0.00 | $-0.34 | ||
| Q2 24 | $-0.04 | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.4M | $60.9M |
| Total DebtLower is stronger | — | $106.0M |
| Stockholders' EquityBook value | $169.1M | $346.6M |
| Total Assets | $214.9M | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $90.4M | — | ||
| Q4 25 | $89.6M | $60.9M | ||
| Q3 25 | $71.5M | $57.7M | ||
| Q2 25 | $72.1M | $70.1M | ||
| Q1 25 | $72.8M | $58.8M | ||
| Q4 24 | $75.4M | $68.8M | ||
| Q3 24 | $53.4M | $76.1M | ||
| Q2 24 | $36.6M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M |
| Q1 26 | $169.1M | — | ||
| Q4 25 | $169.7M | $346.6M | ||
| Q3 25 | $190.2M | $349.3M | ||
| Q2 25 | $187.0M | $355.5M | ||
| Q1 25 | $180.4M | $347.1M | ||
| Q4 24 | $174.3M | $354.6M | ||
| Q3 24 | $133.9M | $370.9M | ||
| Q2 24 | $129.7M | $371.3M |
| Q1 26 | $214.9M | — | ||
| Q4 25 | $225.4M | $508.6M | ||
| Q3 25 | $241.5M | $493.5M | ||
| Q2 25 | $249.0M | $503.6M | ||
| Q1 25 | $265.3M | $470.3M | ||
| Q4 24 | $247.4M | $473.2M | ||
| Q3 24 | $209.2M | $489.3M | ||
| Q2 24 | $200.2M | $430.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $10.3M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 15.8% |
| Capex IntensityCapex / Revenue | 0.6% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.3M | $10.3M | ||
| Q3 25 | $-504.0K | $-581.0K | ||
| Q2 25 | $-745.0K | $-10.5M | ||
| Q1 25 | $-2.9M | $-4.2M | ||
| Q4 24 | $-16.8M | $-4.0M | ||
| Q3 24 | $15.1M | $-10.3M | ||
| Q2 24 | $2.9M | $-6.1M |
| Q1 26 | — | — | ||
| Q4 25 | $18.1M | $9.7M | ||
| Q3 25 | $-624.0K | $-3.4M | ||
| Q2 25 | $-826.0K | $-13.9M | ||
| Q1 25 | $-3.0M | $-8.4M | ||
| Q4 24 | $-17.2M | $-4.2M | ||
| Q3 24 | $15.0M | $-11.7M | ||
| Q2 24 | $2.9M | $-12.8M |
| Q1 26 | — | — | ||
| Q4 25 | 20.5% | 15.8% | ||
| Q3 25 | -0.7% | -5.6% | ||
| Q2 25 | -0.9% | -22.8% | ||
| Q1 25 | -3.1% | -16.0% | ||
| Q4 24 | -17.2% | -8.1% | ||
| Q3 24 | 15.1% | -21.4% | ||
| Q2 24 | 3.1% | -24.2% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 1.4% | 1.0% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.1% | 5.6% | ||
| Q1 25 | 0.1% | 8.1% | ||
| Q4 24 | 0.3% | 0.5% | ||
| Q3 24 | 0.1% | 2.5% | ||
| Q2 24 | 0.0% | 12.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.66× | — | ||
| Q2 25 | -0.19× | — | ||
| Q1 25 | -0.90× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 91.42× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
